Department of Orthopedics, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong Distinct, Chongqing 400010, P. R. China.
Institute of Ultrasound Imaging of Chongqing Medical University; The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong Distinct, Chongqing 400010, P. R. China.
Biomacromolecules. 2021 Nov 8;22(11):4552-4568. doi: 10.1021/acs.biomac.1c00842. Epub 2021 Sep 30.
The repair of bone defects with irregular shapes, particularly in a minimally invasive manner, remains a major challenge. For synthetic bone grafts, injectable hydrogels are superior to conventional scaffolds because they can adapt satisfactorily to the defect margins and can be injected into deeper areas of injury via a minimally invasive procedure. Based on the poly(lactide--glycolide)(PLGA)/1-methyl-2-pyrrolidinone solution reported in our previous study, we successfully synthesized injectable MgO/MgCO@PLGA (PMM) hydrogels, namely, injectable biomimetic porous hydrogels (IBPHs), to accelerate bone regeneration. In addition to exhibiting excellent injectability, PMM hydrogels could transform into porous scaffolds in situ through a liquid-to-solid phase transition and completely fill irregular bone defects via their superb shape adaptability. Moreover, sustainable and steady release of Mg was achieved by regulating the weight ratio of the incorporated MgO and MgCO particles. Via controlled release of Mg, PMM hydrogels significantly promoted proliferation, osteogenic differentiation, migration, and biomineral deposition of immortalized mouse embryonic fibroblasts. More importantly, micro-CT imaging and histological analysis indicated that concomitant with their gradual degradation, PMM hydrogels effectively stimulated in situ bone regeneration in rat calvarial defects with an increase in the bone volume fraction of almost 2-fold compared with that in the control group. These findings suggest that injectable PMM hydrogels can satisfactorily match bone defects and form porous scaffolds in situ and can significantly promote bone regeneration via controllable Mg release. The remarkable features of IPBHs may open a new avenue for the exploration of in situ repair systems for irregular bone defects to accelerate bone regeneration and have great potential for clinical translation.
用不规则形状修复骨缺损,特别是微创修复,仍然是一个主要的挑战。对于合成骨移植物,可注射水凝胶优于传统支架,因为它们可以很好地适应缺损边缘,并且可以通过微创程序注入更深的损伤区域。基于我们之前研究中报道的聚(乳酸-乙醇酸)(PLGA)/1-甲基-2-吡咯烷酮溶液,我们成功合成了可注射的 MgO/MgCO@PLGA(PMM)水凝胶,即可注射仿生多孔水凝胶(IBPH),以加速骨再生。除了表现出良好的可注射性外,PMM 水凝胶还可以通过液-固相变原位转化为多孔支架,并通过其出色的形状适应性完全填充不规则的骨缺损。此外,通过调节掺入的 MgO 和 MgCO 颗粒的重量比,可以实现 Mg 的可持续和稳定释放。通过控制 Mg 的释放,PMM 水凝胶显著促进了永生化小鼠胚胎成纤维细胞的增殖、成骨分化、迁移和生物矿化沉积。更重要的是,微 CT 成像和组织学分析表明,随着它们的逐渐降解,PMM 水凝胶有效地刺激了大鼠颅骨缺损中的原位骨再生,与对照组相比,骨体积分数增加了近 2 倍。这些发现表明,可注射的 PMM 水凝胶可以很好地匹配骨缺损并原位形成多孔支架,并通过可控的 Mg 释放显著促进骨再生。IPBH 的显著特征可能为探索用于不规则骨缺损的原位修复系统开辟新途径,以加速骨再生,并具有很大的临床转化潜力。